HOT FLASHES

This study tests fezolinetant, a non-hormonal drug, for reducing hot flashes in women with hormone-positive breast cancer who are on hormone therapy. About 984 women with moderate to severe hot flashes will take either fezolinetant or a placebo daily for a year. The goal is to se…

This study follows about 1,000 women in menopause who are starting a non-hormonal treatment for bothersome hot flashes and night sweats. Researchers will check if symptoms improve after 12 weeks, and also look at sleep, work productivity, and overall well-being. The goal is to se…

This study tests if a cooling mat, a non-drug option, can reduce hot flashes and night sweats in people receiving hormone therapy for breast or prostate cancer. About 40 participants will use the mat for 8 weeks and track their symptoms. The goal is to see if this simple approach…

This study follows 105 menopausal women in Germany who are taking fezolinetant, a non-hormonal tablet, for hot flashes and night sweats. The goal is to see how much their symptoms improve over 6 months using simple surveys. Participants have virtual check-ins at 1 week, 3 months,…

This study tests a new drug, elinzanetant, to see if it can reduce hot flashes in women with hormone-receptor positive breast cancer who are on hormone-blocking therapy. About 474 women will take either the drug or a placebo for 12 weeks, then all will receive the drug for up to …